Danske Bank’s BioVie BIVI Stock Holding History

Danske Bank’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	1	–	–	﹤0.01%	1118
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1158
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1547
2025 Q3	$2	Buy	+1	New	+$4	﹤0.01%	1463

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Danske Bank's BIVI Position: Q2 2026 in Review

Danske Bank held its BioVie (BIVI) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

Danske Bank first reported a position in BIVI in Q3 2025 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Danske Bank held 1 share of BioVie worth $2 as of Q2 2026.
Danske Bank left its BioVie share count unchanged in Q2 2026.
BioVie made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1118 holding.
Danske Bank first reported a position in BioVie in Q3 2025 and has held it in 4 quarters since.
36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.